The global market for tissue engineering and regeneration products reached $55.9 billion in 2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by 2016 at a compounded annual growth rate (CAGR) of 8.4%.

1. Tissue Engineering and Regeneration: Technologies and Global Markets
 The global market for tissue engineering and regeneration products reached $55.9 billion in
2010, is expected to reach $59.8 billion by 2011, and will further grow to $89.7 billion by
2016 at a compounded annual growth rate (CAGR) of 8.4%.
 The contribution of the U.S region was 45.4% of the total market in 2010 which was a value
of $25.3 billion. The market is expected to reach $26.8 billion by 2011 and will further grow
to $40.4 billion by 2016 at a CAGR of 8.5%.
 The contribution of the European region was 43.3% of the market in 2010, a value of $24.2
billion. The market is expected to reach $25.5 billion by 2011 and will further grow to $36.1
billion by 2016 at a CAGR of 7.2%.
STUDY GOALS AND OBJECTIVES
This report provides an overview of the tissue engineering and regeneration industry. It
describes existing products on the market and offers detailed analysis of the competitive
environments, including new and potential markets for novel therapies and treatments.
The study includes information about significant industry players, trends, and obstacles,
and discusses factors affecting the development of new products, devices, and therapies.
Request a Sample for or Inquire before buying the report Tissue Engineering and
Regeneration Industry
REASONS FOR DOING THIS STUDY
Tissue engineering is a multidisciplinary study involving biology, medicine, and engineering
to create products and devices that will improve or replace biological functions and
organs. The first experiments in tissue engineering date back to the 1960s. More than a
decade ago, the industry introduced the first FDA-approved, tissue-engineered commercial
product—artificial skin substitute.
Although tissue engineering has enormous commercial potential, it seems that this market
develops at a very slow pace. After the introduction of skin substitutes and cartilage
regeneration products in the last decade or so, not much progress has been made in the
industry. Moreover, some of the products have been discontinued. One of the main
reasons for this slow development is the biological complexity of growing organs and
tissue replacements. In addition, current technologies are not efficient enough to make
these products cost-effective alternatives.
Overall, the tissue engineering market is a heterogeneous industry and can be divided into
number of subsectors. Skin substitutes are a relatively developed segment, while tissue-
engineered products for the nervous system comprise a sector that is still in a preliminary
stage. Recent developments in regeneration research, especially stem cell research, give
hope that new scientific breakthroughs will lead to innovative products.
In summary, this report will highlight the main segments of the tissue engineering and
regeneration industry, its major market participants, and current and future market
trends. The report will also highlight specific geographical regions that have individual
market characteristics. Drivers and challenges in each sector of this industry will be
discussed in detail, including forecasts for the next 5 years.

2. SCOPE AND FORMAT
This report is a current and important business tool for evaluating new, commercial
opportunities in the tissue engineering market. The geographic scope of this study covers
the U.S., Europe, and other parts of the world. The market is complex and consists of
many sectors, each affected differently by scientific and technological developments. The
report identifies the primary positive and negative factors in each sector and forecasts
future trends, products, and therapies for each category.
Major points covered in Table of Contents of this report include:
 Chapter- 1: INTRODUCTION - Complimentary
 Chapter- 2: SUMMARY
 Chapter- 3: INTRODUCTION TO TISSUE ENGINEERING AND REGENERATION
INDUSTRY
 Chapter- 4: SKIN TISSUE ENGINEERING MARKET
 Chapter- 5: TISSUE ENGINEERING FOR BONE, CARTILAGE, AND OTHER
CONNECTIVE TISSUES
 Chapter- 6: TISSUE ENGINEERING MARKET FOR CVD
 Chapter- 7: TISSUE ENGINEERING FOR CENTRAL NERVOUS SYSTEM (CNS)
DISEASES
 Chapter- 8: TISSUE ENGINEERING FOR INTERNAL ORGANS
 Chapter- 9: EMERGING SUBMARKETS IN TISSUE ENGINEERING INDUSTRY
 Chapter- 10: U.S. MARKET FOR TISSUE ENGINEERING AND REGENERATION
 Chapter- 11: EUROPEAN MARKET FOR TISSUE ENGINEERING AND REGENERATION
 Chapter- 12: REST OF WORLD (ROW) MARKET FOR TISSUE ENGINEERING AND
REGENERATION
 Chapter- 13: SUMMARY OF GLOBAL MARKET FOR TISSUE ENGINEERING AND
REGENERATION
 Chapter- 14: OVERVIEW OF SELECTED COMPANIES
 Chapter- 15: LIST OF THE COMPANIES MENTIONED IN REPORT
 Tables and Figures
Explore Tables of Contents available in the report Tissue Engineering and Regeneration:
Technologies and Global Markets @
http://www.reportsnreports.com/reports/144588-tissue-engineering-and-
regeneration-technologies-and-global-markets.html.
Report Details:
Published: January 2012
No. of Pages: 200
Price: Single User License – US$4850 Corporate User License – US$8500

3. Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect With Us: